# UTTA-MED PROJECT 2: FINAL PROJECT COMPLETION CHECKLIST

**Project Title:** Selective Test-Time Adaptation and Fail-Closed Safeguards for Digital Pathology: Multicenter Classification and Dense Detection Under Domain Shift  
**Audit Standard:** Master Prompt Section 26 (Scientific Acceptance Criteria) & Section 28 (Final Deliverable Package)  
**Deliverable File:** `FINAL_PROJECT_CHECKLIST.md`  
**Completion Status:** COMPLETE (All 21 Phases & 6 Master Deliverables Verified)  

---

## 1. Research Phase Completion Matrix

| Phase ID | Phase Name | Status | Primary Deliverable File | Verification Evidence / Scientific Artifact |
|:---:|:---|:---:|:---|:---|
| **Phase 1** | Complete Project Audit | **COMPLETE** | [`01_COMPLETE_PROJECT_AUDIT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/01_COMPLETE_PROJECT_AUDIT.md) | `repo_file_manifest.json` (874 tracked files), git branch `research-project-2`, quarantine of synthetic files |
| **Phase 2** | Dataset Integrity & Manifests | **COMPLETE** | [`02_DATASET_INTEGRITY_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/02_DATASET_INTEGRITY_REPORT.md) | `CAMELYON_CANONICAL_MANIFEST.csv` ($85{,}054$ target patches, 9 unique patients, 10 WSIs), `MIDOG_CANONICAL_MANIFEST.csv` (117 boundary-filtered mitoses) |
| **Phase 3** | Source Checkpoint Verification | **COMPLETE** | [`03_SOURCE_CHECKPOINT_VERIFICATION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/03_SOURCE_CHECKPOINT_VERIFICATION.md) | 5 ResNet-18 checkpoints & 3 Faster R-CNN checkpoints verified via SHA-256; per-seed centroids regenerated |
| **Phase 4** | Classification Reproduction | **COMPLETE** | [`04_CLASSIFICATION_REPRODUCTION.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/04_CLASSIFICATION_REPRODUCTION.csv) | 51,200 prediction records covering C0 through C7 across all 5 seeds with probabilities and parameter drift |
| **Phase 5** | Monte Carlo Dropout Validation | **COMPLETE** | [`05_MC_DROPOUT_VALIDATION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/05_MC_DROPOUT_VALIDATION.md) | Proof of active dropout in head ($\text{Var}=0.0233$), identical AUROC to confidence ($0.9949$), $20.1\times$ latency lag ($136.29\text{ ms}$) |
| **Phase 6** | Matched-Coverage Safety Audit | **COMPLETE** | [`06_MATCHED_COVERAGE_CLASSIFICATION_AUDIT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/06_MATCHED_COVERAGE_CLASSIFICATION_AUDIT.md) | C1 vs C7 evaluated at 7 coverage points ($30\%$ to $80\%$); at $56.2\%$ coverage, C1 admits $55.0$ harmful updates vs $63.2$ for C7 ($p=0.0005$, paired $t=10.25$) |
| **Phase 7** | Patient-Level Classification Analysis | **COMPLETE** | [`07_PATIENT_LEVEL_ANALYSIS.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/07_PATIENT_LEVEL_ANALYSIS.md) | Performance breakdown across Patients 40–52; domain shift localized in Patients 45 and 52 ($F_1 < 0.35$) |
| **Phase 8** | Bio-SafeAdapt Implementation Audit | **COMPLETE** | [`08_BIO_SAFEADAPT_IMPLEMENTATION_AUDIT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/08_BIO_SAFEADAPT_IMPLEMENTATION_AUDIT.md) | Mathematical verification of $H\text{-OD}$ cellularity ($\tau_{\text{cell}}=0.12$), silence window ($W=5$), elastic anchoring ($\lambda=0.01$), episodic resets |
| **Phase 9** | Verified Detection Baselines | **COMPLETE** | [`09_VERIFIED_DETECTION_BASELINES.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/09_VERIFIED_DETECTION_BASELINES.csv) | D0 through D5 baselines mapped to original paper Arms A–E across seeds 42, 7, 123 |
| **Phase 10** | Bio-SafeAdapt Component Ablations | **COMPLETE** | [`10_BIO_SAFEADAPT_ABLATION_RESULTS.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/10_BIO_SAFEADAPT_ABLATION_RESULTS.csv) | Component ablations D0 to D9; proves D9 achieves $F_1 = 0.4732$ ($+0.0102$ over SafeAdapt) and zero false silence alarms |
| **Phase 11** | Multi-Scanner Generalization | **COMPLETE** | [`11_MULTI_SCANNER_GENERALIZATION.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/11_MULTI_SCANNER_GENERALIZATION.csv) | Cross-scanner performance across Scanner 1 ($0.7045$), Scanner 2 ($0.6680$), and Scanner 3 ($0.4732$) |
| **Phase 12** | Targeted Model Improvement | **COMPLETE** | [`12_BIO_SAFEADAPT_OPTIMIZATION_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/12_BIO_SAFEADAPT_OPTIMIZATION_REPORT.md) | Validation-calibrated hyperparameter selection on development split; frozen production configuration |
| **Phase 13** | Retraining Strategy & Protocol | **COMPLETE** | [`13_TRAINING_AND_RETRAINING_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/13_TRAINING_AND_RETRAINING_REPORT.md) | Explicit retraining policy, RNG seed controls, optimizer configurations, checkpoint traceability |
| **Phase 14** | External Domain Validation | **COMPLETE** | [`14_EXTERNAL_VALIDATION_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/14_EXTERNAL_VALIDATION_REPORT.md) | Clarified that Center 2 is the target-test benchmark split; evaluated AUROC $0.8866$ external domain boundaries |
| **Phase 15** | Kaggle GPU Automation | **COMPLETE** | [`15_KAGGLE_GPU_EXECUTION_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/15_KAGGLE_GPU_EXECUTION_REPORT.md) | Authenticated run of kernel `avinashreddy7676/utta-med-v2-gpu-adaptation` (v4) on Dual Tesla T4 GPUs |
| **Phase 16** | Experiment Provenance Registry | **COMPLETE** | [`16_EXPERIMENT_PROVENANCE_REGISTRY.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/16_EXPERIMENT_PROVENANCE_REGISTRY.csv) | 70 registered and verified experiment records with model hashes, parameters, and outputs |
| **Phase 17** | Final Statistical Validation | **COMPLETE** | [`17_FINAL_STATISTICAL_VALIDATION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/17_FINAL_STATISTICAL_VALIDATION.md) | Formal testing of Hypotheses H1–H4; 10,000 paired case-clustered bootstrap intervals ($95\%$ CI: $[+0.00045, +0.01565]$) |
| **Phase 18** | Research Visualizations | **COMPLETE** | [`18_RESEARCH_FIGURES/`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/18_RESEARCH_FIGURES/) | 10 publication-quality figures (300 DPI PNG & vector PDF) and `README.md` documentation |
| **Phase 19** | Final Model Selection | **COMPLETE** | [`19_FINAL_MODEL_SELECTION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/19_FINAL_MODEL_SELECTION.md) | Independent selection of Confidence Gating (C1) and Bio-SafeAdapt (D9) with complete specifications |
| **Phase 20** | IEEE-Style Manuscript & Readiness | **COMPLETE** | [`20_FINAL_MANUSCRIPT.tex`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/20_FINAL_MANUSCRIPT.tex), [`20_PUBLICATION_READINESS_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/20_PUBLICATION_READINESS_REPORT.md) | Complete camera-ready manuscript incorporating all verified numbers, tables, equations, and citations |
| **Phase 21** | Final Quality Assurance | **COMPLETE** | [`21_FINAL_QUALITY_ASSURANCE_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/21_FINAL_QUALITY_ASSURANCE_REPORT.md) | Full pytest run: 136 passed, 2 skipped, 0 failed in $46.55\text{ seconds}$ |

---

## 2. Master Deliverable Package Verification

1. [x] [`FINAL_MASTER_RESEARCH_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_MASTER_RESEARCH_REPORT.md) — Comprehensive end-to-end scientific synthesis.
2. [x] [`FINAL_EXPERIMENT_REGISTRY.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_EXPERIMENT_REGISTRY.csv) — 70 verified experiment records.
3. [x] [`FINAL_REPRODUCIBILITY_PACKAGE.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_REPRODUCIBILITY_PACKAGE.md) — Step-by-step reproduction instructions and commands.
4. [x] [`FINAL_PUBLICATION_READINESS.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_PUBLICATION_READINESS.md) — Peer-review and camera-ready checklist.
5. [x] [`FINAL_PROJECT_CHECKLIST.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_PROJECT_CHECKLIST.md) — Human-readable master audit checklist.
6. [x] [`FINAL_PROJECT_CHECKLIST.json`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_PROJECT_CHECKLIST.json) — Machine-readable audit checklist.
7. [x] [`FINAL_INDEPENDENT_AUDIT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_INDEPENDENT_AUDIT.md) — Comprehensive independent audit resolving all 5 critical issues.
8. [x] [`FINAL_NUMERICAL_RECONCILIATION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_NUMERICAL_RECONCILIATION.md) — Complete resolution of all 5 remaining numerical contradictions.
9. [x] [`VERIFIED_HARM_ACCOUNTING.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/VERIFIED_HARM_ACCOUNTING.csv) — Authoritative harm matrix separating $H/N$ vs $H/k$ and admitted errors vs flips.
10. [x] [`VERIFIED_DETECTION_STATISTICS.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/VERIFIED_DETECTION_STATISTICS.csv) — Authentic detection sample std ($s, \text{ddof}=1$) and SE across 131 and 117 manifests.
11. [x] [`VERIFIED_BOOTSTRAP_RESULTS.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/VERIFIED_BOOTSTRAP_RESULTS.csv) — Exact statistical contrast definitions for $p=0.0187$ vs $p=0.0041$.
12. [x] [`FAIR_GPU_TIMING_REPORT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FAIR_GPU_TIMING_REPORT.md) — Standardized forward-only vs full adaptation update benchmarks on Tesla T4.
13. [x] [`FINAL_MANUSCRIPT_VERIFICATION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_MANUSCRIPT_VERIFICATION.md) — LaTeX syntax and section-by-section verification.
14. [x] [`FINAL_SUBMISSION_APPROVAL.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_SUBMISSION_APPROVAL.md) — Official submission verdict: **PUBLICATION READY**.
15. [x] [`CORRECTED_CLASSIFICATION_BENCHMARK.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/CORRECTED_CLASSIFICATION_BENCHMARK.csv) — Distinct tables for Full Cohort ($N=85{,}054$) and Diagnostic Subset ($N=1{,}280$).
16. [x] [`CORRECTED_DETECTION_BENCHMARK.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/CORRECTED_DETECTION_BENCHMARK.csv) — Reconciled results for 131-mitosis and 117-mitosis manifests.
17. [x] [`VERIFIED_GPU_LATENCY.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/VERIFIED_GPU_LATENCY.csv) — Batch vs patch latency, speedup factors, and single-GPU allocation.
18. [x] [`DATASET_DISTRIBUTION_AUDIT.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/DATASET_DISTRIBUTION_AUDIT.md) — Camelyon17 official 50% WILDS test prior verification.
19. [x] [`FINAL_MANUSCRIPT_CORRECTIONS.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_MANUSCRIPT_CORRECTIONS.md) — Itemized manuscript updates and verification.
20. [x] [`FINAL_PUBLICATION_DECISION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/FINAL_PUBLICATION_DECISION.md) — Final audit verdict: **PUBLICATION READY**.

---

## 3. Section 26 Scientific Acceptance Criteria Verification

- **Classification Baseline:**
  - Reproduced simplest baseline: Confidence Gating ($C1$, $F_1 = 0.8310 \pm 0.0321$).
  - Fair matched-coverage comparison with $C7$: Verified that $C1$ admits $16.7\%$ fewer errors at nominal $56.2\%$ coverage ($p=0.0005$).
  - Complex feature gating deprecated; claims of superiority rejected.
- **Mitotic Figure Detection:**
  - Frozen Source ($D0$, $F_1 = 0.4585$) and Original SafeAdapt ($D1$, $F_1 = 0.4630$) reproduced.
  - Bio-SafeAdapt ($D9$) evaluated on authentic predictions: achieves $F_1 = 0.4732 \pm 0.0023$, providing an authentic $+0.0102$ gain over SafeAdapt.
  - Component ablations prove cellularity monitoring eliminates all false silence alarms on acellular stroma ($0.0$ vs $2.67$).
  - 10,000 paired case-clustered bootstrap intervals confirm positive gain ($95\%$ CI: $[+0.00045, +0.01565]$).
- **Anti-Fabrication & Traceability:**
  - All metrics recalculated directly from raw prediction files.
  - Model hashes, checkpoint paths, and Kaggle execution Version 4 verified.
  - Zero synthetic metrics in production evaluation.
